ETHICAL CONCERNS REGARDING COMMERCIALIZATION OF DEEP BRAIN STIMULATION FOR OBSESSIVE COMPULSIVE DISORDER
The United States Food and Drug Administration's recent approval of the commercial use of Deep Brain Stimulation (DBS) as a treatment for Obsessive Compulsive Disorder (OCD) will be discussed within the context of the existing USA regulatory framework. The purpose will be to illustrate the curr...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
2012
|
| In: |
Bioethics
Year: 2012, Volume: 26, Issue: 8, Pages: 440-446 |
| Further subjects: | B
innovative surgery
B neurotechnology B Oversight B Bioethics B Regulation B deep brain stimulation B industry-driven approach B Obsessive Compulsive Disorder |
| Online Access: |
Presumably Free Access Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1781884099 | ||
| 003 | DE-627 | ||
| 005 | 20230426163123.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211211s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1467-8519.2011.01886.x |2 doi | |
| 035 | |a (DE-627)1781884099 | ||
| 035 | |a (DE-599)KXP1781884099 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Erickson-Davis, Cordelia |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a ETHICAL CONCERNS REGARDING COMMERCIALIZATION OF DEEP BRAIN STIMULATION FOR OBSESSIVE COMPULSIVE DISORDER |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The United States Food and Drug Administration's recent approval of the commercial use of Deep Brain Stimulation (DBS) as a treatment for Obsessive Compulsive Disorder (OCD) will be discussed within the context of the existing USA regulatory framework. The purpose will be to illustrate the current lack of regulation and oversight of the DBS market, which has resulted in the violation of basic ethical norms. The discussion will focus on: 1) the lack of available evidence on procedural safety and efficacy, 2) the numerous conflicts of interest held by research investigators, and 3) the ambiguity of both aforementioned categories due to an inherent lack of transparency in the research. It is argued that in order to address these issues, ethical analyses of DBS for psychiatric disorders must include the role of the industry forces that have become the primary impetus for this research. As such, DBS for OCD serves as an important case example in studies of neurotechnology and innovative surgery. | ||
| 650 | 4 | |a Oversight | |
| 650 | 4 | |a Regulation | |
| 650 | 4 | |a innovative surgery | |
| 650 | 4 | |a neurotechnology | |
| 650 | 4 | |a industry-driven approach | |
| 650 | 4 | |a Obsessive Compulsive Disorder | |
| 650 | 4 | |a Bioethics | |
| 650 | 4 | |a deep brain stimulation | |
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 26(2012), 8, Seite 440-446 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnas |
| 773 | 1 | 8 | |g volume:26 |g year:2012 |g number:8 |g pages:440-446 |
| 856 | |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1467-8519.2011.01886.x |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [deprecated] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1111/j.1467-8519.2011.01886.x |x Resolving-System |z lizenzpflichtig |3 Volltext |7 1 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1467-8519.2011.01886.x |x Verlag |z lizenzpflichtig |3 Volltext |7 1 |
| 935 | |a mteo | ||
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4019007071 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1781884099 | ||
| LOK | |0 005 20211211042815 | ||
| LOK | |0 008 211211||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2021-12-10#D4BD4CF19FFE18149819FC1D03BF2F1F32808C8C | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| LOK | |0 939 |a 11-12-21 |b l01 | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||
| STA | 0 | 0 | |a Regulation |
| STB | 0 | 0 | |a Régulation |
| STC | 0 | 0 | |a Regularización |
| STD | 0 | 0 | |a Regolazione |
| STG | 0 | 0 | |a Regularização |
| STH | 0 | 0 | |a Регуляция |
| STI | 0 | 0 | |a Ρύθμιση |
